This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Jan;36(1):104-9.

doi: 10.1016/j.gyobfe.2007.11.007.

[Against medicalizing the postmenopause with HRT]

[Article in French]

B Guyot¹

Affiliations

Affiliation

¹ Département de gynécologie-obstétrique et biologie de la reproduction, centre hospitalier intercommunal (CHI) Poissy-Saint-Germain-en-Laye, Poissy, France. bguyot@chi-poissy-st-germain.fr

PMID: 18248840
DOI: 10.1016/j.gyobfe.2007.11.007

Comment

[Against medicalizing the postmenopause with HRT]

[Article in French]

B Guyot. Gynecol Obstet Fertil. 2008 Jan.

. 2008 Jan;36(1):104-9.

doi: 10.1016/j.gyobfe.2007.11.007.

Author

B Guyot¹

Affiliation

¹ Département de gynécologie-obstétrique et biologie de la reproduction, centre hospitalier intercommunal (CHI) Poissy-Saint-Germain-en-Laye, Poissy, France. bguyot@chi-poissy-st-germain.fr

PMID: 18248840
DOI: 10.1016/j.gyobfe.2007.11.007

No abstract available

PubMed Disclaimer

Comment in

[Hormonal replacement therapy: pros... and cons].
Bréart G. Bréart G. Gynecol Obstet Fertil. 2008 Jan;36(1):97. doi: 10.1016/j.gyobfe.2007.11.006. Epub 2008 Jan 4. Gynecol Obstet Fertil. 2008. PMID: 18178118 French. No abstract available.

Comment on

[Hormone replacement therapy: the pros].
Jamin C, Madelenat P. Jamin C, et al. Gynecol Obstet Fertil. 2008 Jan;36(1):98-103. doi: 10.1016/j.gyobfe.2007.11.008. Gynecol Obstet Fertil. 2008. PMID: 18248839 French. No abstract available.

Similar articles

[Should estrogen replacement therapy be questioned?].
Tiitinen A. Tiitinen A. Duodecim. 2000;116(16):1669-71. Duodecim. 2000. PMID: 12001440 Finnish. No abstract available.
Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale.
Berg AO; U.S. Preventive Services Task Force. Berg AO, et al. Am J Nurs. 2003 Jun;103(6):83-91. Am J Nurs. 2003. PMID: 12802162 Review. No abstract available.
Health risks after cessation of postmenopausal hormone therapy.
Pines A, Sturdee D, Birkhäuser M; International Menopause Society. Pines A, et al. Climacteric. 2008 Jun;11(3):179-80. doi: 10.1080/13697130802176228. Climacteric. 2008. PMID: 18568782 No abstract available.
Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
Birkhäuser MH, Panay N, Archer DF, Barlow D, Burger H, Gambacciani M, Goldstein S, Pinkerton JA, Sturdee DW. Birkhäuser MH, et al. Climacteric. 2008 Apr;11(2):108-23. doi: 10.1080/13697130801983921. Climacteric. 2008. PMID: 18365854 No abstract available.
Justification for the use of HRT in the long-term prevention of osteoporosis.
Stevenson JC. Stevenson JC. Maturitas. 2005 Jun 16;51(2):113-26. doi: 10.1016/j.maturitas.2005.01.012. Maturitas. 2005. PMID: 15917151 Review.

See all similar articles

Cited by

GnRH-a-Induced Perimenopausal Rat Modeling and Black Cohosh Preparations' Effect on Rat's Reproductive Endocrine.
Chen J, Wang H, Dong Z, Liu J, Qin Z, Bao M, Yu H, Zhang S, Zhang W, Qi C, Wu J. Chen J, et al. Front Endocrinol (Lausanne). 2021 Dec 24;12:683552. doi: 10.3389/fendo.2021.683552. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 35002948 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science